Takasaki M, Konoshima T, Fujitani K, Yoshida S, Nishimura H, Tokuda H, Nishino H, Iwashima A, Kozuka M
Kyoto Pharmaceutical University, Japan.
Chem Pharm Bull (Tokyo). 1990 Oct;38(10):2737-9. doi: 10.1248/cpb.38.2737.
Twelve euglobals from Eucalyptus globulus and their twenty-six related compounds were examined for their inhibitory effects on Epstein-Barr virus activation by a short-term in vitro assay. The results showed that most of the euglobals having monoterpene structures, and euglobal-III (8) had strong inhibitory activity. Grandinol (18), homograndinols (19 and 20), and compounds 26, 27, 28, and 32 showed stronger inhibitory effects. Based on the results, the structural requirements for the activity of these compounds were discussed.
